More importantly, however, most patients with a wait-and-scan approach in our cohort were diagnosed during a time when significance of molecular markers like IDH mutation and TERT promotor mutation were less well established and treatment strategies in low grade gliomas varied from wait-and-scan to complete resection of all visible tumor on MRI. The gene discussed is TERT; the disease is glioma.